Skip to Main Content

Our Part of the Moonshot

In early 2016, the U.S. government launched the National Cancer Moonshot initiative to eliminate cancer as we know it.
Clinical trials are a key part of that moonshot, as they allow for advancements in cancer prevention, detection and treatment.
“When people take part in clinical trials, they are moving the needle on cancer care,” said Barb Croney, vice-president of Research and Education at Samaritan Health Services.
The Samaritan Cancer Program team is well-versed in how clinical trials help patients whose cancer might stop responding to available treatment options. Having clinical trials provides “more tools in the treatment toolbox,” said Croney, allowing oncologists to help patients live with the disease. 
One of the many clinical trials through Samaritan, is a phase II trial where participants are able to take a drug that could provide hope for women with ovarian cancer.

Patients are screened and vetted closely, and tissue samples are sent to bench researchers. Principal investigator for the trial is Kimberly McGregor, MD, a medical oncologist or the Samaritan Cancer Program.
“There is so much discovery at such a rapid pace,” said Croney. “It is an exciting time for advancements in a disease that impacts so many of us.”
Visit to learn more.